`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`APOTEX INC.
`Petitioner
`v.
`ALCON PHARMACEUTICAL, LTD.
`Patent Owner
`_____________________
`
`CASE IPR2013-00428
`Patent 8,268,299
`_____________________
`
`APOTEX, INC.’S UPDATED MANDATORY NOTICES
`
`
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`Petitioner, Apotex, Inc., hereby files updated mandatory notices pursuant to
`
`37 C.F.R. 42.8(a)(3).
`
`
`
`
`
`A. Lead and Back-Up Counsel (37 C.F.R. § 42.8(b)(3))
`
`Petitioner designates the following back-up counsel:
`
`Eldora L. Ellison (Reg. No. 39,967) phone: 202.772.8508
`Lead Counsel:
`Back-up Counsel: Ralph W. Powers III (Reg. No. 63,504) phone: 202.772.8876
`Back-up Counsel: David H. Holman (Reg. No. 61,205) phone: 202.772.8989
`Back-up Counsel: H. Keeto Sabharwal*
`
`
` phone: 202.772.8511
`Back-up Counsel: Paul A. Ainsworth*
`
`
` phone: 202.772.8783
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`Address:
`
`1100 New York Avenue, NW
`Washington, DC 20005
`202.371.2600 (reception)
`202.371.2540 (facsimile)
`eellison-PTAB@skgf.com
`tpowers-PTAB@skgf.com
`dholman-PTAB@skgf.com
`keetos-PTAB@skgf.com
`painsworth@skgf.com
`
`A power of attorney is being filed concurrently with this notice.
`
`*H. Keeto Sabharwal and Paul A. Ainsworth have been admitted pro hac vice.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`- 1 -
`
`
`
`APOTEX, INC.’s UPDATED MANDATORY NOTICES
`CASE IPR2013-00428
`
`
`
`
`B.
`
`Service Information (37 C.F.R. § 42.8(b)(4))
`
`Please direct all correspondence regarding this proceeding to the lead
`
`counsel at the address listed above. Patent Owner also consents to electronic
`
`service by email to eellison-PTAb@skgf.com and tpowers-PTAB@skgf.com.
`
`
`
`The Patent Trial and Appeal Board is hereby authorized to charge any fees
`
`associated with this proceeding to Deposit Account 19-0036 (Customer ID
`
`No. 45324).
`
`
`
`
`
`
`
`
`
`
`
` Respectfully Submitted,
` STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
` /Eldora L. Ellison/
` Eldora L. Ellison, Ph.D.
`Date: February 24, 2014
` Lead Attorney for Petitioner Apotex
`
`
`
`
`
`1100 New York Avenue, N.W. Registration No. 39,967
`Washington, D.C.20005-3934
`(202) 371-2600
`
`- 2 -
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. §§ 42.6(e))
`
`
`
`The undersigned hereby certifies that the above-captioned “Apotex
`
`Inc.’s Updated Mandatory Notices” was served in its entirety on February 24,
`
`2014, upon the following parties via e-mail:
`
`
`
`Stanley E. Fisher
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, NW
`
`Washington, DC 20005
`
`
`Tel: (202) 434-5289
`
`
`Fax: (202) 434-5029
`
`
`sfisher@wc.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Barry L. Copeland
`Alcon Research, Ltd.
`6201 South Freeway
`Mail Code TB4-5
`Fort Worth, TX 76134
`Tel: 817-551-4322
`Fax: 817-551-4610
`barry.copeland@alcon.com
`patent.docketing@alcon.com
`
`
`
` Respectfully Submitted,
` STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
` /Eldora L. Ellison/
` Eldora L. Ellison, Ph.D.
`Date: February 24, 2014
` Lead Attorney for Petitioner Apotex
`
`
`
`
`
`1100 New York Avenue, N.W. Registration No. 39,967
`Washington, D.C.20005-3934
`(202) 371-2600
`1798403.1